The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer

The Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer and the Medical Care Cost in Iijima Town

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00596401

Enrollment

3000

Registered

2008-01-17

Start date

2007-09-30

Completion date

2021-12-31

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eradication, Gastric Cancer, Helicobacter Pylori, Medical Care Cost

Brief summary

Recently, the preventive effect of Helicobacter pylori (Hp) eradication treatment on the incidence of gastric cancer has been reported. By Hp eradication treatment being performed for Hp-infected people in Iijima town, we will evaluate whether the incidence of gastric cancer and/or the medical care cost can be reduced as compared with those in the previous years.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to 69 Years

Healthy volunteers

Yes

Inclusion criteria

* People who live in Iijima town at their age of 19 to 69 years

Design outcomes

Primary

Measure	Time frame
the annual incidence of gastric cancer in Iijima town	10 years

Secondary

Measure	Time frame
The annual medical care cost in Iijima town	10 years

Countries

Japan

Outcome results